Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean flunixin meglumine and phenyl?
Displaying drugs 1376 - 1400 of 14835 in total

Black sea bass

Black sea bass allergenic extract is used in allergenic testing.
Approved

Cashew fruit

Cashew fruit extract is used in allergenic testing.
Approved

Field mushroom

Field mushroom allergenic extract is used in allergenic testing.
Approved

White mustard seed

White mustard seed allergenic extract is used in allergenic testing.
Approved

Theobroma cacao whole

Theobroma cacao, whole, allergenic extract is used in allergenic testing.
Approved

Muskmelon

Muskmelon allergenic extract is used in allergenic testing.
Approved

American hazelnut

American hazelnut allergenic extract is used in allergenic testing.
Approved

Fennel

Approved
Experimental

Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen

Approved

Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen

Approved

Boldo leaf extract

Boldo leaf extract allergenic extract is used in allergenic testing.
Approved
Experimental

Influenza virus type B (Victoria)

Approved

Influenza virus type B (Yamagata)

Approved

Influenza virus type B

Approved

Cinnamon oil

Approved
Experimental

Autologous peripheral blood-derived CD34+ cells

Autologous peripheral blood-derived CD34+ cells, or CLBS119 (a proprietary version being developed by Caladrius Biosciences, Inc.), are hematopoietic stem cells. It is also a cell therapy being investigated by Caladrius Biosciences in the clinical trial NCT04522817 (CLBS119 for Repair of COVID-19 Induced Pulmonary Damage).
Approved
Investigational

Bifidobacterium bifidum

Approved
Experimental

Goldenseal

Approved
Experimental

Juniper tar

Approved
Experimental

Influenza A virus subtype H1N1 haemagglutinin, recombinant

Approved

Influenza B virus Victoria lineage haemagglutinin, recombinant

Approved

Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)

Approved

Streptococcus pneumoniae type 10A capsular polysaccharide diphtheria CRM197 protein conjugate antigen

Streptococcus pneumoniae type 10A capsular polysaccharide diphtheria CRM197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 10A individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides...
Approved

Streptococcus pneumoniae type 12F capsular polysaccharide diphtheria CRM197 protein conjugate antigen

Streptococcus pneumoniae type 12F capsular polysaccharide diphtheria CRM197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 12F individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides...
Approved

Streptococcus pneumoniae type 15B capsular polysaccharide diphtheria CRM197 protein conjugate antigen

Streptococcus pneumoniae type 15B capsular polysaccharide diphtheria CRM197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 15B individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides...
Approved
Displaying drugs 1376 - 1400 of 14835 in total